Bank of Montreal’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Buy |
9,578
+642
| +7% | +$35.8K | ﹤0.01% | 1974 |
|
|
2025
Q1 | $432K | Buy |
8,936
+2,686
| +43% | +$130K | ﹤0.01% | 2042 |
|
|
2024
Q4 | $241K | Buy |
6,250
+270
| +5% | +$10.4K | ﹤0.01% | 2379 |
|
|
2024
Q3 | $266K | Buy |
+5,980
| New | +$266K | ﹤0.01% | 2554 |
|
|
2023
Q3 | – | Sell |
-310,000
| Closed | -$8.68M | – | 3614 |
|
|
2023
Q2 | $8.68M | Buy |
+310,000
| New | +$8.68M | ﹤0.01% | 945 |
|
|
2022
Q1 | – | Sell |
-21,400
| Closed | -$734K | – | 3700 |
|
|
2021
Q4 | $734K | Sell |
21,400
-405
| -2% | -$13.9K | ﹤0.01% | 2083 |
|
|
2021
Q3 | $385K | Sell |
21,805
-42,475
| -66% | -$750K | ﹤0.01% | 2834 |
|
|
2021
Q2 | $2.84M | Sell |
64,280
-25,793
| -29% | -$1.14M | ﹤0.01% | 1765 |
|
|
2021
Q1 | $2.4M | Sell |
90,073
-43,501
| -33% | -$1.16M | ﹤0.01% | 1469 |
|
|
2020
Q4 | $2.76M | Buy |
133,574
+132,169
| +9,407% | +$2.73M | ﹤0.01% | 1418 |
|
|
2020
Q3 | $30K | Sell |
1,405
-400
| -22% | -$8.54K | ﹤0.01% | 3241 |
|
|
2020
Q2 | $32K | Buy |
1,805
+1,196
| +196% | +$21.2K | ﹤0.01% | 3270 |
|
|
2020
Q1 | $4K | Sell |
609
-2,185
| -78% | -$14.4K | ﹤0.01% | 3424 |
|
|
2019
Q4 | $19K | Buy |
2,794
+724
| +35% | +$4.92K | ﹤0.01% | 3811 |
|
|
2019
Q3 | $25K | Sell |
2,070
-753
| -27% | -$9.09K | ﹤0.01% | 3475 |
|
|
2019
Q2 | $34K | Sell |
2,823
-8,203
| -74% | -$98.8K | ﹤0.01% | 3413 |
|
|
2019
Q1 | $139K | Buy |
11,026
+10,405
| +1,676% | +$131K | ﹤0.01% | 2544 |
|
|
2018
Q4 | $4K | Buy |
621
+3
| +0.5% | +$19 | ﹤0.01% | 3813 |
|
|
2018
Q3 | $6K | Buy |
618
+9
| +1% | +$87 | ﹤0.01% | 3751 |
|
|
2018
Q2 | $4K | Sell |
609
-514
| -46% | -$3.38K | ﹤0.01% | 3849 |
|
|
2018
Q1 | $10K | Sell |
1,123
-4,807
| -81% | -$42.8K | ﹤0.01% | 3485 |
|
|
2017
Q4 | $123K | Buy |
5,930
+5,430
| +1,086% | +$113K | ﹤0.01% | 2642 |
|
|
2017
Q3 | $9K | Sell |
500
-24
| -5% | -$432 | ﹤0.01% | 3439 |
|
|
2017
Q2 | $6K | Buy |
+524
| New | +$6K | ﹤0.01% | 3523 |
|